A pilot randomized trial of older adults with mild cognitive impairment given either daily low-dose lithium carbonate or placebo for 2 years met its feasibility target, according to results published ...
Oral lithium at low doses may help limit deteriorating verbal memory for patients diagnosed with Alzheimer disease.
A once-daily dose of a medication, which averaged 195 mg, produced blood levels significantly lower than those typically pursued by psychiatrists. However, it succeeded in generating a weak signal ...